Group items tagged

Peyronie's disease (Pdy) is a sexually transmitted disease caused by the infectious agent of the same name - the bacteria known as folliculitis. Peyronie's disease is more common in men than in women, with approximately 3% of men being affected by it. This disease is most commonly associated with poor oral hygiene, although sexual intercourse can also cause it. The precise causes of this condition are not known, but heredity, diabetes, and injury to the urethra may all be contributing factors. The primary treatment of Peyronies is the surgical removal of the papillae, which are found on the tip of the penis. Peyronie's disease (Pdy) is clinically classified as an intervertebral disk disease and is often difficult to diagnose. The growing prevalence of Peyronie's disease around the globe is propelling the growth of the Peyronie's disease treatment market. According to the American Academy of Family Physicians, it primarily affects men between 45 and 60 years of age, although an age range of 18 to 80 years. This disease occurs more often in men between 40 to 70 years older. Improved healthcare facilities across developing regions coupled with the availability of the multiple treatment options due to advancement in technology are again propelling the market growth. Moreover, the increasing geriatric population around the globe is further projected to foster the growth of Peyronie's disease treatment market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-incidence-of-sexually.html

Enteric diseases are caused by micro-organisms such as parasites, bacteria, and viruses that cause intestinal illness. Enteric disease is caused by bacteria that are found inside of the small intestine. The term enteric describes the area where these bacteria attach to the lining of the small intestine, and it is generally thought that there are approximately five hundred different strains of this type of bacteria. An individual is not necessarily at risk for developing enteric disease, but those who have a family history of the disease are particularly at risk. Enteric diseases most often result from consuming contaminated water or food and some can spread from person to person. The emergence of COVID-19 (the novel coronavirus) is expected to propel the growth of the enteric disease testing market. For instance, according to the World Health Organization (WHO), worldwide, as of 5:01pm CET, 11 February 2021, there have been 106,991,090 confirmed cases of COVID-19, including 2,347,015 deaths. Increasing prevalence of enteric diseases worldwide and increasing launches and approvals of new products are expected to drive the enteric disease testing market growth. For instance, in October 2019, Mobidiag received CE-IVD marking for its Novodiag Stool Parasites test for the detection of intestinal parasites from stool samples. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/02/the-emergence-of-covid-19-to-augment.html

Myelofibrosis Treatment includes medications and surgery. There are drugs and medicines which are used to cure myelofibrosis. Myelofibrosis is a muscle disease and various types of myelofibrosis treatment are available in the market to cure this condition. The muscle disease is caused due to myelodysplasia, a genetically determined trait that prevents the muscle from growing properly. Myelofibrosis is also known as spider veins, lying in regions close to the skin, like the armpits, groin, elbows, and knees. Myelofibrosis is the most common type of connective tissue disease. These medicines are generally used to control and stop the progress of the disease, after which, they suppress the activity of the immune system. Various types of steroids are used as medicines for myelofibrosis, to control the activity of the immune system and thereby stop the disease in its tracks. One of the most common drugs for myelofibrosis treatment is prednisone, which is generally used along with steroids. However, to treat spider veins and not myelofibrosis, a compound called Finasteride is used. The most important part of myelofibrosis treatment is a regular check-up, as early as 18 months of the disease a doctor can monitor the progress of the disease. Myelofibrosis treatment also includes physical therapy and other treatments to improve the symptoms of myelofibrosis. The main driving factor influencing the growth of the myelofibrosis treatment market is the increasing prevalence of myelofibrosis in emerging economies. For instance, according to Gleneagles Global Hospitals, the yearly incidence rate of myelofibrosis in India is 0.3 to 1.5 cases per 100,000 individuals. Most of the times these cases goes unnoticed since it is sometimes asymptomatic or less severe. Moreover, the market is estimated to grow owing to a large number of R&D investments, a large cluster of patients suffering from myelofibrosis, and better reimbursement policies. Read more @ https://coherentmarketinsights-bl

Hyperphosphatemia is a condition caused by high levels of phosphorous or phosphate in the blood. This condition may be due to decreased emission of phosphate, excessive intake of phosphate, and the shift of phosphate from intracellular to extracellular. High phosphate levels in the blood can be avoided with the use of phosphate binders or by dietary restrictions. Phosphate is a chemical found in the human body and contains a mineral called phosphorous. It is important for the development of bones and teeth and also converts food into energy for the body. Some other possible causes of hyperphosphatemia include low levels of parathyroid hormone, high levels of vitamin D, uncontrolled diabetes, and diabetic ketoacidosis. The factors such as the growing geriatric population and increasing prevalence of chronic diseases worldwide are expected to drive the hyperphosphatemia drugs market in the coming future. Hyperphosphatemia is a primary cause of mortality and morbidity in people with chronic kidney disease. According to the Centers for Disease Control and Prevention (CDC), around 37 million adults in the United States are likely to have chronic kidney disease and most are undiagnosed. It is rare in the general population, but in people with chronic kidney disease, the rate of hyperphosphatemia is at least 70%. Since the increased risk of death from heart disease and hyperphosphatemia are associated with each other. This, in turn, increases the risk of heart disease in people suffering from hyperphosphatemia. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/increasing-prevalence-of-chronic-kidney.html

Gastroesophageal Reflux Disease (GERD) is a chronic condition that is characterized by the regurgitation of stomach contents into the throat. GERD is also known as acid reflux disease and it occurs in people of all ages. In milder cases, GERD can be effectively treated with simple pharmacological therapies or by altering a patient's diet. In more severe cases, esophageal surgery might be necessary to remove the troublesome esophageal sphincter and/or improve a patient's general physical condition. GERD can develop when the lower esophageal valve relaxes or becomes weakened. The diagnosis of GERD and gastroesophageal reflux disease can be done by examining the medical history and symptoms. Although acid-reflux disease typically affects the upper body, some of its symptoms can extend down the esophageal tract, making GERD particularly troubling for people who sit or stand for long periods of time. This problem has given rise to a variety of different approaches to treatment, including invasive, surgical treatments, non-surgical treatments and more novel, non-invasive therapeutic approaches. The latest treatment option on the table involves using pharmaceuticals, such as selective serotonin reuptake inhibitors (SSRIs), to help reduce the effects of GERD. There are a number of advantages to this strategy. For starters, SSRIs are believed to have numerous side effects that tend to make them less attractive to certain groups of patients. Electrical stimulation (ESD) is another common form Gastroesophageal Reflux Disease (GERD) Treatment Devices. This technique involves the use of electrodes attached to the esophageal wall to generate a varying amount of electrical current. Antirheumatic drugs, which often cause symptoms similar to those of severe heart disease, are sometimes added to the mixture. A major disadvantage of using plicator devices with ESD is that the procedure can only be performed on an outpatient basis, requiring a patient to remain in the hospital for a fe

Surgical drain cleaning equipment plays an integral part in ensuring maximum productivity in the healthcare industry. These devices are meant to evacuate fluid and prevent the buildup of air at the surgical site. This is done with the use of vacuum or wall suction. Majority of these devices use negative pressure therapy to drain fluid from the surgical site. Demand for such medical devices has increased at a rapid pace due to their various advantages which make them highly useful. Increasing prevalence of chronic diseases such as cancer, cardiovascular disease, and kidney disease is expected to drive growth of the global surgical drainage devices market during the forecast period. According to the World Health Organization (WHO), in 2018, around 9.6 million deaths were attributed to cancer across the globe. According to the same source, around 70% of deaths from cancer occur in emerging economies. Moreover, according to the WHO, around 17.9 million people die from cardiovascular diseases each year globally. According to the same source, in 2010, around 2.3-3.7 million people were suffering from end-stage kidney disease. These above-mentioned diseases require significant surgical procedures and hence, it is boosting the demand for surgical drainage devices. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/surgical-drainage-devices-market-is.html

A biologic drug (biologics) is a product that is produced from living organisms or contains components of living organisms. Biologic drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Biologics drugs are derived from a wide variety of natural sources such as human, animal, or microorganisms by using biotechnology. Moreover, Biologics include a wide variety of products such as blood and blood components, vaccines, tissues, allergenic, gene therapy, somatic cells, and recombinant therapeutic proteins. Novel therapies and new technologies are emerging to create new biologics, which holds a prominent future for the biologics market. The market is majorly driven by the increasing prevalence of chronic diseases across the globe, growing capital investment by key players, and higher acceptability and increasing demand for innovative therapies. For instance, according to the National Health Council, around 157 million Americans are expected to have more than one chronic disorder by 2020. Moreover, according to the World Health Organization, diabetes, cancer, and cardiovascular diseases account for around 1.6 million, 9 million, and 17.9 million deaths each year, respectively. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/11/increasing-prevalence-of-chronic.html

A cancer registry is the cancer cases which are registered in a population or specific country. In whole world mortality rate due to cancer is 20%. In USA cancer is the second largest disease of causing death after heart disease. Recently in 2016 estimated that 595,690 people die from this disease according to cancer statistics of National Cancer Institute USA.

PET-CT Scanner devices are highly advanced devices that help physicians make a correct diagnosis of the disease earlier, reducing unnecessary suffering to patients. They are widely used in a number of applications in the healthcare industry. One such medical application is in the field of diagnosing certain diseases, wherein the scanning of the body tissues, the positron emission tomography or PET-CT is used as a diagnostic tool. By using the ionization technique, scientists are able to locate and map the location of the abnormalities in a patient's body. This technology is a boon to mankind as it has helped in reducing the number of deaths caused by various diseases due to their early detection. The growing prevalence of cancer, HIV, and cardiovascular disease is driving the PET-CT scanner device market growth. Out of these chronic diseases, cancer held the highest share in the market. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. According to the U.S. Department of Health & Human Services, an estimated 36,400 new HIV infections occurred in the United States in 2018. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/pet-ct-scanner-devices-gaining-traction.html

What Is Leprosy Disease? Leprosy is a chronic, granulomatous infection caused by the... According to historical records, this disease spread through the slave trade and migration routes from... In this article, we talk about the causes, symptoms, and treatment of Leprosy

Like TB, leprosy is caused by a bacterium. The bacterium is Mycobacterium Leprae. It was discovered by Armauer Hansen in Norway in 1873. This is why it is also called Hansen's disease. Although its bacterial nature was known at the time, it was not considered infectious.

Cardiac markers are special antibodies measured in the blood to measure heart function. They can also be used in the detection or early diagnosis of certain diseases. Although they're usually associated with myocardial infarction, they can also be indicative of many other conditions. For instance, hyperthyroidism and thyroid prophylaxis can result in an elevated elevation in plasma marker levels. As per the American Heart Association (AMA), in 2016, cardiovascular disease accounted for 17.6 million deaths across the globe. The ECG is one of the most useful cardiac marker testing device. It measures the cardiac output and provides detailed information about heart conditions. This test is used to diagnose heart diseases and the complications that can arise from the disease. ECG is one of the most widely used tests. ECG is conducted while the patient is lying down on the table. A technician places electrodes either in or on the skin surface. The test is normally performed for different purposes. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/03/cardiac-marker-testing-devices-have.html

Graft-versus-host disease (GvHD) is a systemic disorder and a common complication after allogeneic hematopoietic stem cell transplant. The condition can be subclassified into acute classic GVHD, persistent, recurrent, or late-onset acute GVHD, classic chronic GVHD, and overlap syndrome. High adoption of hematopoietic stem cell transplantation and increasing prevalence of certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia is expected to propel growth of the graft versus host disease (GvHD) market. For instance, according to Leukemia and Lymphoma Society, 176,200 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2019. Moreover, around 30,000 patients undergo allogeneic hematopoietic stem cell transplant annually in the United States, with approximately 20% to 85% developing aGvHD that affects the skin, gut, or liver. Increasing number of clinical trials for graft versus host disease is expected to offer lucrative growth opportunities for players in the graft versus host disease (GvHD) market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/high-adoption-of-hematopoietic-stem.html

Tonometers, also known as hand-pieces, are mechanical devices that measure eye pressure and the flow of fluid through the cornea, lens and retina. They play an important role in various fields of medicine such as ophthalmology, optometry, clinical measurements, and medical lasers. The most common use of a tonometer is for measuring intraocular pressure or the pressure of the fluid within the eye, which occurs during normal vision. Other uses include in the diagnosis and treatment of certain eye diseases, for obtaining an accurate reading of the pressure of tears during the night, and to prevent or detect possible internal bleeding or infections in the eye. Tonometry is a diagnostic test primarily used to detect glaucoma, one of the leading cause of irreversible blindness worldwide. Increasing incidence or prevalence of chronic eye diseases such as glaucoma is expected to propel the tonometers market growth. For instance, according to the Centers for Disease Control and Prevention, more than 3 million people in the United States have glaucoma. It is the second leading cause of blindness worldwide after cataract. Around 50% of people with glaucoma don't know they have the disease. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/01/increasing-prevalence-of-chronic-eye.html

Bone Marrow Transplantation (or BMT) is the specialized treatment of patients suffering from diseases like multiple sclerosis, Parkinson's disease, and multiple myeloma. Hematologic stem cells are usually taken from bone marrow. They are harvested and divided into two types namely autologous and allogenic. Autologous cells are implanted in the diseased area and they work against the disease while allogeneic cells are taken from the bone marrow and used for transplants. In general, BMT is more successful when compared to other treatment modalities. In Germany, around 13,895 people were diagnosed with leukemia with around 4% of them aged 15 years and below. One common cause of blood transfusions is the occurrence of sickle cell anemia. Sickle cell anemia is a disorder wherein the red blood cells of the body are shaped differently from normal. These blood cells are thick and might contain large amounts of iron. A bone marrow transplant can be given after the occurrence of sickle cell anemia. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/08/bone-marrow-transplant-has-become.html

Overview: The connection between the Body, its physiology and particularly biochemistry, have been linked to the mind with particular emphasis upon emotions and stress. This can be easily substantiated in common everyday situations. Anyone who has observed a facial red flush triggered by some sort of embarrassment can attest to the foregoing connection. The emotions and stress play a key role in many if not all diseases and disorders: due to the vastness of the subject, we will focus on the application of the mind/body connection(MBC) to skin. This serves as an introduction to the field of psych dermatology which, although still in its infancy in the USA, is expanding as evidence with regard to the psychological component related to the etiology of skin diseases continues to grow. Concurrently, the field of Alternative techniques IN mind/body treatments continue to grow in leaps and bounds providing effective methods for integration with conventional cosmetic and dermaceutical treatment. This provides a dual complimentary pathway both for prevention and treatment of any/most skin disorders. Expanding on this model, we have already shown how the mind influences the body as per the above example. This general proposition can be extended to include specific skin disorders such as acne rosacea psoriasis eczema and atopic dermatitis to name a few. We will concentrate on Acne for the sake of this discussion. First, focusing on the B component of the BMC model, the primary lesion associated with acne is the formation microcomodones, which are small enough to proceed undetected until larger comodones appear later in the cycle. The latter cycle is initiated by peroxidation of squalene and unsaturated fatty acids present in human sebum. This leads to the foregoing lesions and pro- inflammatory mediators such as cytokines and interleukins followed by an increase of p.acnes on the epithelial cell wall together with increased film formation of the p.acnes is the same area This

Laboratory centrifuge equipment is used to separate materials from the liquid medium into which they dissolve, depending on their shape, size, density, and viscosity. It works on the principle of centrifugation. A centrifuge is a device that uses centrifugal force to separate various components of a fluid. It is also used to separate cellular elements such as red blood cell (RBC) and white blood cell (WBC) from a blood sample, remove protein precipitate from analytical sample, separate solid or semisolid precipitant from the analytical sample, and isolate macromolecules such as RNA, DNA, and lipids from the cell. Laboratory centrifuge equipment is widely used to conduct a diversity of laboratory work, and thus, there is a growing demand for reliable, durable, and multifunctional laboratory centrifuge equipment. With increasing diagnostics and research and development activities, the demand for such equipment is also increasing. According to the World Health Organization (WHO), in 2018, noncommunicable diseases (chronic diseases), such as diabetes, cancer, and heart disease, kill around 41 million people each year, equivalent to 71% of all deaths worldwide. Non-transmissible chronic disease is the most pressing health problem in Mexico in recent decades. Read more @ https://coherentmarketinsights-cmi.blogspot.com/2021/03/laboratory-centrifuge-equipment-used-to.html

Medical devices play an important role in the delivery of many health care services. Medical supplies refer to any item (basic medical products) that is necessary for treating injury or illness. In the medical parlance, medical supplies generally are understood to mean items that are low cost, disposable, easily available, and in high enough quantity so that the buying department has enough standing orders to ensure the supply of the items when they are in demand. Increasing prevalence of chronic diseases across the globe, especially in North America, is expected to propel the growth of the medical supplies market. According to the Centers for Disease Control and Prevention (CDC), chronic diseases such as diabetes, cancer, and heart disease are the leading causes of death and disability in the United States. Moreover, proactive government initiatives, increasing demand for infection control measures to curb the occurrence of hospital-acquired infections, the rising number of surgical procedures, and increasing demand for medical supplies are expected to augment the growth of the medical supplies market. Read more @ https://coherentmarketinsights-blog.blogspot.com/2021/03/increasing-demand-for-emergency-medical.html

Nutritional supplements are any dietary supplement that is used to treat nutritional deficiencies in the body. Nutritional supplements are intended to provide nutrients that may otherwise not be consumed in sufficient quantities, for instance, amino acids, proteins, minerals, vitamins, or other nutritional ingredients. Products are usually ingested in liquid, tablet, or capsule form. However, at certain times in life, many individuals often need more trace elements, minerals, vitamins, etc. That's when it is a good time to take supplements. The health benefits associated with nutritional supplements are improved cardiovascular health and reduction in signs of aging among others. Increasing prevalence of chronic diseases (such as diabetes, cancer, and heart disease) and the growing geriatric population worldwide is expected to drive the growth of the nutritional supplements market. According to the Centers for Disease Control and Prevention (CDC), chronic diseases are the leading causes of death and disability in the United States. Moreover, growing awareness among people about the benefits of dietary supplements is also expected to propel the market growth. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/growing-awareness-about-benefits-of.html

Enteral feeding devices technological advanced medical device used to deliver nutrition food directly to the stomach to the bedridden patient suffering from chronic diseases such as cancer and neurological disorder. The increase in the cases of malnutrition and premature birth cases around the globe is a prime factor driving growth of the enteral feeding devices market. Moreover, the growing prevalence of chronic diseases such as cancer and cardiovascular disease is another key factor fostering the market growth of the enteral feeding devices. According to the World Health Organization, cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths occur due to cancer. Around 70% of deaths from cancer occur in low- and middle-income countries. Furthermore, increasing global expenditure on the healthcare sector for improving the patient care is further projected to augment the growth of the enteral feeding devices market. From the geographical perspective, North America is projected to gain significant growth over the forecast period and this is attributed to the high presence of the geriatric population prone to chronic disease that leads to digestive ailments. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/enteral-feeding-devices-to-gain.html

Advanced Therapy Medicinal Products (ATMPs) offer a real and tangible hope for many different chronic illnesses for which there currently are no or limited therapeutic options. The science and technology that support these products are developing rapidly and therefore the products that are on the market today will undoubtedly continue to improve and grow in effectiveness and capability over time. Patients around the world are now beginning to experience the benefits of these improved products. One such product is Stem Cell Therapy, which uses stem cells from healthy cells taken from the patient's own body. High prevalence of Alzheimer's disease is expected to propel growth of the advanced therapy medicinal products market. For instance, According to the data from Alzheimer's Association, around 5.7 million people in the U.S. were suffering from Alzheimer's disease in 2018. Moreover, increasing adoption of gene therapy is also expected to aid in growth of the market. For instance, in March 2020, AVROBIO, Inc., a clinical-stage gene therapy company, announced that a second patient in the AVR-RD-04 Phase 1/2 clinical trial in cystinosis has been enrolled and has completed apheresis. Read more @ https://coherentmarketinsights-blog.blogspot.com/2020/12/high-prevalence-of-alzheimers-disease.html